sch 23982 has been researched along with 4-hydroxy-2-nonenal in 1 studies
Studies (sch 23982) | Trials (sch 23982) | Recent Studies (post-2010) (sch 23982) | Studies (4-hydroxy-2-nonenal) | Trials (4-hydroxy-2-nonenal) | Recent Studies (post-2010) (4-hydroxy-2-nonenal) |
---|---|---|---|---|---|
87 | 0 | 0 | 3,034 | 26 | 1,103 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shin, Y; Sidhu, A; Uh, M; White, BH | 1 |
1 other study(ies) available for sch 23982 and 4-hydroxy-2-nonenal
Article | Year |
---|---|
Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adenylyl Cyclases; Aldehydes; Animals; Benzazepines; Cell Line; Cell Membrane; Colforsin; Corpus Striatum; Cyclic AMP; Cysteine Proteinase Inhibitors; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Guanylyl Imidodiphosphate; Humans; Hydrogen Peroxide; Lipid Peroxidation; Male; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D5 | 2003 |